Agios Pharmaceuticals Inc Book/Share
What is the Book/Share of Agios Pharmaceuticals Inc?
The Book/Share of Agios Pharmaceuticals Inc is 21.08
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with book/share similar to Agios Pharmaceuticals Inc
- YASKAWA Electric has Book/Share of 21.06
- Metals Exploration plc has Book/Share of 21.07
- Hathway Cable and Datacom has Book/Share of 21.07
- Care Property Invest NV has Book/Share of 21.07
- BioMarin Pharmaceutical has Book/Share of 21.08
- Expeditors International of Washington has Book/Share of 21.08
- Agios Pharmaceuticals Inc has Book/Share of 21.08
- SpringWorks Therapeutics has Book/Share of 21.11
- Q2 Inc has Book/Share of 21.12
- Schoeller-Bleckmann Oilfield Equipment Aktiengesellschaft has Book/Share of 21.12
- Mynaric AG has Book/Share of 21.12
- SB One Bancorp has Book/Share of 21.12
- NSK has Book/Share of 21.12